Karl Sotlar

发表

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

K. Lennert, K. Wolff, R. Parwaresch, 2001, Leukemia research.

Detection and Typing of Human Papillomavirus by E6 Nested Multiplex PCR

D. Wallwiener, K. Dietz, K. Sotlar, 2004, Journal of Clinical Microbiology.

Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria

M. Triggiani, A. Órfão, H. Kluin-Nelemans, 2007, European journal of clinical investigation.

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis

T. Haferlach, W. Hofmann, S. Schnittger, 2016, Leukemia.

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis

S. Schoenberg, W. Hofmann, K. Sotlar, 2016, Leukemia.

Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge

K. Sotlar, P. Valent, W. Sperr, 2004, Journal of Clinical Pathology.

Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.

C. Garbe, G. Rassner, K. Sotlar, 2000, The Journal of investigative dermatology.

Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event

T. Haferlach, W. Hofmann, S. Schnittger, 2015, Leukemia.

Expression of the target receptor CD33 in CD34+/CD38−/CD123+ AML stem cells

D. Printz, K. Sotlar, P. Valent, 2007, European journal of clinical investigation.

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

M. Triggiani, T. Haferlach, A. Órfão, 2015, Leukemia.

An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL)

K. Sotlar, P. Valent, H. Horny, 2006, Journal of Clinical Pathology.

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis

M. Triggiani, A. Órfão, H. Kluin-Nelemans, 2014, Allergy.

Acute myeloid leukaemia with t(8;21) associated with “occult” mastocytosis. Report of an unusual case and review of the literature

H. Bernd, K. Sotlar, P. Valent, 2004, Journal of Clinical Pathology.

Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts

W. Sperr, W. Rabitsch, Daniel Ivanov, 2023, International journal of molecular sciences.

Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

M. Triggiani, T. Haferlach, A. Órfão, 2014, Leukemia.

Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia

H. Griesser, H. Stein, T. Marafioti, 2000, Molecular pathology : MP.

Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens

K. Sotlar, P. Valent, H. Horny, 2003, Journal of clinical pathology.

Human papillomavirus type 16-associated primary squamous cell carcinoma of the rectum.

K. Sotlar, H. Selinka, R. Kandolf, 2001, Gastroenterology.

The normal range of baseline tryptase should be 1-15 ng/ml and covers healthy individuals with hereditary alpha tryptasemia.

M. Triggiani, A. Órfão, S. Galli, 2023, The journal of allergy and clinical immunology. In practice.

Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis

A. Fabarius, H. Horny, G. Metzgeroth, 2024, Cancers.

A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosis

A. Fabarius, H. Horny, G. Metzgeroth, 2024, Scientific reports.

Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3

K. Sotlar, P. Went, A. Tzankov, 2008, Journal of Clinical Pathology.

Late transplant‐associated thrombotic microangiopathy verified in bone marrow biopsy specimens is associated with chronic GVHD and viral infections

J. Tischer, A. Hausmann, Karl Sotlar, 2024, European journal of haematology.